Company Information
CIN
Status
Date of Incorporation
08 July 1988
State / ROC
Mumbai / ROC Mumbai
Last Balance Sheet
31 March 2023
Last Annual Meeting
26 September 2023
Paid Up Capital
246,601,500
Authorised Capital
750,000,000
Directors
Pooja Sameer Hiremath
Director/Designated Partner
almost 2 years ago
almost 2 years ago
Ramachandra Kaundinya Vinnakota
Director/Designated Partner
about 2 years ago
about 2 years ago
Berjis Minoo Desai
Individual Subscriber
about 2 years ago
about 2 years ago
Anish Dilip Swadi
Director/Designated Partner
over 2 years ago
over 2 years ago
Sugandha Jaidev Hiremath
Director/Designated Partner
over 2 years ago
over 2 years ago
Shrikrishna Kiran Adivarekar
Director/Designated Partner
over 2 years ago
over 2 years ago
Babasaheb Neelkanth Kalyani
Director/Designated Partner
over 2 years ago
over 2 years ago
Amit Babasaheb Kalyani
Director/Designated Partner
over 2 years ago
over 2 years ago
Shivani Bhasin
Director/Designated Partner
over 2 years ago
over 2 years ago
Sunita Babasaheb Kalyani
Director/Designated Partner
about 6 years ago
about 6 years ago
Pallavi Swadi Anish
Beneficial Owner
about 6 years ago
about 6 years ago
Ranjit Gobindram Shahani
Director/Designated Partner
over 7 years ago
over 7 years ago
Unni Kadankote Kannan
Director/Designated Partner
over 25 years ago
over 25 years ago
Prakash Vasantlal Mehta
Director/Designated Partner
over 31 years ago
over 31 years ago
Past Directors
Ravindra Kumar Goyal
Director
over 4 years ago
over 4 years ago
Axel Karl Willi Kleemann
Director
over 11 years ago
over 11 years ago
Wolfgang Welter
Director
over 14 years ago
over 14 years ago
Sameer Jai Hiremath
Director
over 17 years ago
over 17 years ago
Jai Vishwanath Hiremath
Managing Director
over 17 years ago
over 17 years ago
Bimal Kishore Raizada
Director
over 23 years ago
over 23 years ago
Shivkumar Kheny
Director
over 29 years ago
over 29 years ago
Sham Vinayak Wahalekar
Company Secretary
about 33 years ago
about 33 years ago
Patents
Abstract
A PROCESS FOR THE PREPARATION OF 2-CYANOIMINO-l, 3-THIAZOLIDINE USING AN INORGANIC CARBONATE
The present invention relates to a process for the preparation of substantially pure 2-cyanoimino-1, 3-thiazolidine of Formula-I
by cyclization of dimethyl N-cyanoiminodithiocarbona...
A process for the preparation of l-[2-(dimethylamino)-l-(4-methoxyphenyl) ethyl] cyclohexanol of Formula-II, which is substantially free from a spiro compound 5-(4-methoxyphenyl)-3-methyl-3-aza-l-oxaspiro(5.5)- undecane and acid addition salts thereof by dissolving an acid addition salt of l-[2-amino-l-(4-methoxyphe...
ABSTRACT
A process for the preparation of 2-cyanoimino-l, 3-thiazolidine using aqueous ammonia
The present invention relates to a process for the preparation of substantially pure 2-cyanoimino-1, 3-thiazolidine of Formula-1
by cyclization of dimethyl N-cyanoiminodithiocarbonate with 2-aminoethanethiol or the s...
The present invention relates to crystalline forms of gabapentin and processes for preparing the same. The present invention particularly relates to crystalline forms of gabapentin form II and Form IIB.
The invention also relates to gabapentin form IA and form IB. The gabapentin forms IA and IB are hydrated forma...
The present invention relates to a commercially viable novel process for manufacturing Vildagliptin in high yield with high chemical and chiral purity.
The present invention discloses a process for the preparation of dibenzothiazepinone compounds of Formula I.
The process for preparation of a dibenzothiazepinone compound of Formula I comprises reaction of compound of formula II in the presence of an acid catalyst comprising phosphorus pentoxide and methanesulfo...
The present invention provides an improved process for the preparation of a compound of formula (I),
The present invention describes a process for the preparation of l,2-dialkoxy-3-fluorobenzene compounds of formula I
Picture I
wherein:
R3 and R4 are each independently a linear or a branched C1-C20 alkyl, a C3-C8 cycloalkyl, a C7-C15 alkylaryl or a C4-C7 cycloalkyl alkyl; said process comprising: halogenating 2...
The present disclosure relates to a process for the preparation of pregabalin of formula 1;
said process comprises the steps of; obtaining 2-Cyano-5-methyl-hex-2-enoic acid alkyl ester of formula II, by reacting isovaleraldehyde and alkyl cyanoacetate, in presence of salts of weak acid and weak base or weak base...
ABSTRACT
A process for the preparation of 2-cyanoiinino-l, 3-thiazoIidine using an alkali metal
alkoxide
The present invention relates to a process for the preparation of substantially pure 2-cyanoimino-1, 3-thiazolidine of
by cyclization of dimethyl N-cyanoiminodithiocarbonate with 2-aminoethanethiol or th...
A process for the preparation of 1 -[2-(dimethylamino)-1 -(4-methoxyphenyl)ethyl]cyclohexanol (venlafaxin) of formula (4) (R=OMe, R]=Me), said process comprising the steps of; dissolving compound (3) (R=OMe) or its acid addition salt in an alcohol, to form an alcoholic solution of compound (3), adding formaldehyde t...
A process for the preparation of compound of formula (3) (R=OMe, OH) said process comprising the steps of: dissolving the substituted phenylacetonitrile (2) (R=OMe, OH) in an alcohol and ammonium salt to obtain a reaction mixture, and treating the reaction mixture with hydrazine hydrate in the presence of a noble me...
The present invention relates to a process for the preparation of l-[2-amino-l-(4-substituted phenyl)ethyl]cyclohexanol (3) (where R is OMe, OH), said process comprising the steps of; subjecting a reaction mixture of substituted phenylacetonitrile (2) in alcohol, an organic acid, and a hydrogenating catalyst in th...
The present invention relates to compounds trans (E) and cis (Z) stereoisomers of 4-t-butyl gabapentin of formula (11) and (12) and a process for the preparation of the said stereoisomers.
The invention describes an improved method for producing halo-dialkoxybenzenes of formula (I) such as 1-fluoro-2. 3-dialkoxybenzene as well as 2-fluoro-1. 4-dialkoxybenzene.
by reacting commercial 2-fluorophenol is reacted with an allyl halide in N-methylpyrrolidone (NMP) followed by rearranging the resultant 2-...
The present invention relates to a process for the preparation of a pharmaceuticallly acceptable acid addition salt of l-amino-3, 5-dimethyl adamantane of Formula-A,
said process comprising: reacting l-halo-3, 5-dimethyl adamantane with acetonitrile in the presence of an organic acid to obtain N-acetamido-3, 5-d...
A Process for the Preparation of Valproic Acid
The present invention relates to a process for the preparation of valproic acid of Formula-I,
said process comprising hydrolysing epoxy nitrile of Formula-II, in presence of a phase transfer catalyst, water and optionally an alkali or alkaline earth metal halide.
...
The present invention relates to a process for the preparation of substantially pure 1-(aminomethyl)-l-cyclohexane acetic acid hydrochloride of formula (II) viz. gabapentin hydrochloride through gabalactam (I) which in turn arises from 3,3-pentamethylene glutarimide of formula (IV). The imide, 3,3-pentamethylene glu...
Abstract
"A process for the preparation of l-benzyl-4-[(5,6-dimethoxy-l-indanon)-2-yl]methylpiperidine and acid addition salts thereof
The present invention relates to a process for preparing donepezil, l-benzyl-4-[(5, 6-dimethoxy-l-indanon)-2-yl] methylpiperidine, of Formula-II and acid addition salts thereof,
...
The present invention relates to a process for the preparation of tetrahydrocarbazolone derivatives in the absence of solvent, more particularly for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl)- 1H-imidazole-1 -yl)methyl]-4H-carbazol-4-one free from exomethylene carbazolone in the absence of solvent....
A process for preparation of E-isomer of l-(4-methylphenyl)-l-(2-pyridyl)-3-pyrrolidinoprop-1 -ene (Formula-1), and acid addition salts thereof, said process comprising; dehydrating l-(4-methylphenyl)-l-(2-pyridyl)-3-pyrrolidinopropan-l-ol (Formula III) followed by adding a base solution to obtain a mixture of E and...
The present invention relates to provide an improved and novel process for the preparation of Apixaban (I), which is simple, economical, metal-free, efficient, user and environment friendly, moreover commercially viable.
ABSTRACT
DIOXANE SOLVATE OF PROTHIOCONAZOLE AND PROCESS FOR PREPARATION THEREOF
The present invention relates to a stable crystalline dioxane solvate of prothioconazole formula (I) and process for preparation thereof. The present invention also relates to crystalline 1,4-dioxane solvate of prothioconazole (II)...
ABSTRACT
PROCESS FOR PREPARATION OF 5-BROMO-1,2,3-TRICHLOROBENZENE
The present invention relates to a process for preparation of 5-bromo-1,2,3-trichlorobenzene of formula (I) in simple, economical manner with high yield. The 5-bromo-1,2,3-trichlorobenzene of formula (I)is used in preparation of 1-(3,4,5-trichl...
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF THIABENDAZOLE
The present invention relates to an improved process for preparing thiabendazole of formula (I) with high yield, high purity, in economical and commercially viable manner for agricultural and pharmaceutical use.
(I)
ABSTRACT
CONTINUOUS PROCESS FOR THE PREPARATION OF
GABAPENTIN SALT
The present invention relates to the field of chemistry for the preparation of gabapentin salt of formula (I). More particularly the present invention relates to a continuous process for preparation of gabapentin salt (I) by means of the Hofm...
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF A KEY INTERMEDIATE OF GEMFIBROZIL
The present invention relates to an improved process for the preparation of 5-bromo-2,2-dimethyl-pentanoic acid isobutyl ester of formula (I), a key intermediate of gemfibrozil, in an environment friendly and commercially via...
The invention relates to a commercially viable process for manufacturing 4-cyanothiazole (I) from 4-methylthiazole (II) using a novel ammoxidation catalyst composed of oxides of Antimony, Calcium, Chromium, Iron, Potassium, Titanium, Vanadium and Zirconium is disclosed with high selectivity and chemical purity.
...
The present invention relates to an improved process for the preparation of Butorphanol tartrate of formula (I),
(I)
The present invention relates to a commercially viable novel process for manufacturing sitagliptin of formula (I) in high chemical & chiral purity alongwith higher yield.
Sitagliptin (I)
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
The present invention relates to provide an improved process for the preparation of sitagliptin (I) and its pharmaceutical acceptable salts thereof, which is simple, economical, efficient, user and env...
The present invention relates to an improved process for the preparation of trifloxystrobin of formula (I), which is simple, economical, efficient, user and environment friendly, moreover commercially viable with higher yield and chemical purity.
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF ERTUGLIFLOZIN AND INTERMEDIATE THEREOF
The present invention relates to an improved process for the preparation of ertugliflozin of formula (I) and intermediate thereof, in an environment friendly and commercially viable manner with safer conditions in high y...
ABSTRACT
PROCESS FOR THE PREPARATION OF 2-AMINO-N-(2,2,2-TRIFLUOROETHYL) ACETAMIDE AND SALTS THEREOF
The present invention relates to an improved process for the preparation of 2-amino-N-(2,2,2-trifluoroethyl) acetamide of formula (I) and salts (IA) thereof, in an environment friendly and commercially viable m...
ABSTRACT
Process for the preparation of a key intermediate of Gemfibrozil
The present invention relates to an improved process for the preparation of 5-bromo-2,2-dimethyl-pentanoic acid isobutyl ester of formula (I), a key intermediate of Gemfibrozil, by using radical initiator in an environment friendly and c...
The present invention relates to an economical, enzyme catalyzed and commercially viable greener process for manufacturing pregabalin of formula (I) in high yield with high chemical and chiral purity.
ABSTRACT
SUBSTANTIALLY PURE CLARITHROMYCIN 9-OXIME AND ITS PREPARATION THEREOF
The present invention relates to substantially pure Clarithromycin 9-oxime more particularly Clarithromycin 9(E)-oxime having purity more than 98% and corresponding (Z)-isomer not more than 1%. The present invention further relates ...
ABSTRACT
PROCESS FOR PURIFICATION OF FLURALANER
The present invention relates to a process for purification of Fluralaner of formula (I). The present invention further relates to a process for purification of Fluralaner of formula (I) with purity more than 99%, in simple, economic and commercially viable manne...
ABSTRACT
AN INDUSTRIAL SCALE PROCESS FOR THE PREPARATION OF PROTHIOCONAZOLE
The present invention relates to an industrial scale process for the preparation of Prothioconazole (I), which is simple, economical, efficient, user and environment friendly, moreover commercially viable with higher yield and greater ...
ABSTRACT
AN INDUSTRIAL PROCESS FOR RESOLUTION OF CHLOCYPHOS
The present invention relates to a process for resolution of Chlocyphos of Formula (I) to obtain corresponding (S)- or (R)-isomers. The present invention further relates to a process of obtaining (S)-Chlocyphos using (R)-(+)-a-methylbenzylamine and (R...
ABSTRACT
PROCESS FOR THE PREPARATION OF 3,5-DICHLORO-2,2,2-TRIFLUOROACETOPHENONE
The present invention relates to an improved process for the preparation of 3,5-Dichloro-2,2,2-Trifluoroacetophenone of formula (I). The present invention further provides an improved process for the preparation of Fluralaner usin...
ABSTRACT
AN IMPROVED PROCESS FOR PREPARATION OF DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE
The present invention relates to an improved process for preparation of Dapagliflozin propanediol monohydrate of formula (I). The invention further relates to an improved process for the preparation of substantially pure inte...
ABSTRACT
“A SIMPLE PROCESS FOR THE PREPARATION OF FAVIPIRAVIR AND ITS INTERMEDIATES THEREOF”
The present invention relates to a simple process for the preparation of Favipiravir of Formula (I). The present invention further relates to an improved process for the preparation of substantially pure 2-aminomalonam...
ABSTRACT
AN IMPROVED PROCESS FOR PREPARATION OF EMPAGLIFLOZIN AND ITS CRYSTALLINE POLYMORPH
The present invention relates to an improved process for preparation of Empagliflozin of formula (I). The invention further relates to preparation of crystalline form of Empagliflozin and its particle size having coarse...
ABSTRACT
IMPROVED PROCESS FOR PREPARATION OF R,S-ESTER INTERMEDIATE OF PREGABALIN
The present invention relates to an improved process for preparation of R,S-ester of formula (I) using proline or substituted proline. The present invention further provides an improved process for the preparation of Pregabalin u...
ABSTRACT
“A PREPARATION OF SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE”
The present invention relates to an improved process for the preparation of Sitagliptin hydrochloride monohydrate of formula (I). The invention further relates to Sitagliptin hydrochloride monohydrate of formula (I) which is prepared from phosph...
ABSTRACT
AN EFFICIENT PROCESS FOR THE PREPARATION OF ERTUGLIFLOZINL-PYROGLUTAMIC ACID AND INTERMEDIATES THEREOF
The present invention relates to an efficient process for the preparation of Ertugliflozin L-pyroglutamic acid of formula (I) and intermediate thereof, in environment friendly conditions. The present...
ABSTRACT
AN IMPROVED PROCESS FOR PREPARATION OF PROHEXADIONE AND ITS CALCIUM SALT
The present invention relates to an improved and efficient process for the preparation of Prohexadione and its calcium salt of formula (I). The present invention further relates to a one step process for preparation of ethyl 3,5-...
ABSTRACT
INDUSTRIAL METHOD OF PRODUCING BENZISOTHIAZOLINONE
The present invention relates to an industrial method for the preparation of Benzisothiazolinone formula (I), which is simple, economical, efficient, user and environment friendly, moreover commercially viable with higher yield and chemical purity.
...
ABSTRACT
SUBSTANTIALLY PURE VILDAGLIPTIN AND A PROCESS THEREOF
The present invention relates to substantially pure Vildagliptin having an imine N-oxide impurity not more than 0.15% and a process for the preparation thereof. The invention further relates to a process for the preparation of substantially pure Vi...
ABSTRACT
INDUSTRIAL METHOD FOR PRODUCING 2-BUTYL-1,2-BENZISOTHIAZOL-3-ONE
The present invention relates to an industrial method for the preparation of 2-Butyl-1,2-benzisothiazol-3-one of formula (I) in an environment friendly and commercially viable manner with high yield and high chemical purity.
...
An Improved Process For The Preparation Of Intermediate Of Trifloxystrobin In Single Isolation Stage
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF INTERMEDIATE OF TRIFLOXYSTROBIN IN SINGLE ISOLATION STAGE
The present invention relates to an improved process for the preparation of intermediate of Trifloxystrobin in single isolation stage. The present invention provides an improved process for the prepara...
ABSTRACT
AN INDUSTRIAL PROCESS FOR THE PREPARATION OF 3-BROMO-1-(3-CHLOROPYRIDIN-2-YL)-1H-PYRAZOL-5-CARBOXYLIC ACID
The present invention relates to an industrial process for the preparation of 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-carboxylic acid of formula (I). The present invention further involves ...
ABSTRACT
AN INDUSTRIALY SCALABLE PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL
The present invention relates to a process for the preparation of Olmesartan Medoxomil of formula (I) using single solvent in robust and industrially scalable manner.
ABSTRACT
A SCALABLE PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE GLYCINE TERT-BUTYL ESTER AND ITS SALT THEREOF
The present invention relates to a scalable and efficient process for the preparation of substantially pure Glycine tert-butyl ester.The invention further relates to preparation of substantially ...
The present invention relates to a process for the preparation of 4-acetyl-1-naphthoic acid or its derivatives of formula (I) where R is hydrogen or C1-C4 alkyl, using novel compounds. The invention further relates to use of compound (I) for the preparation of Afoxolaner.
ABSTRACT
SUBSTANTIALLY PURE (5-BROMO-2-CHLOROPHENYL) (4-ETHOXYPHENYL) METHANONE AND PREPARATION THEREOF
The present invention relates to substantially pure (5-bromo-2-chlorophenyl) (4-ethoxyphenyl) methanone of formula (IV) having undesired isomer of formula (IVA) less than 1%. The invention further relates to...
ABSTRACT
A PROCESS FOR THE PREPARATION OF VENLAFAXINE HYDROCHLORIDE HAVING COARSER PARTICLE SIZE
The present invention relates to a process for the preparation of venlafaxine hydrochloride having coarser particle sized90 not less than 300 microns, d50 not less than 50 microns, and d10 not less than 20 microns....
ABSTRACT
AN INDUSTRIAL PROCESS FOR THE PREPARATION OF SUBSTANTIALLY PURE 2,3-O-ISOPROPYLIDENE-D-RIBOFURANOSE
The present invention relates to an industrial process for the preparation of 2,3-O-Isopropylidene-D-ribofuranose of formula (I). The intermediate of formula (I) is used for the preparation of Varitriol...
ABSTRACT
PROCESS FOR THE PREPARATION OF BUPROPION HYDROBROMIDE FORM-II
The present invention relates to the preparation of crystalline bupropion hydrobromide form - II by treating bupropion hydrobromide in an aqueous alcoholic solvent.
ABSTRACT
A PREPARATION AND PURIFICATION OF CRYSTALLINE SITAGLIPTIN PHOSPHATE MONOHYDRATE
The present invention relates to a process for the preparation and/or purification of crystalline Sitagliptin phosphate monohydrate of formula (I). The invention further relates to preparation of crystalline Sitagliptin ph...
ABSTRACT
A PROCESS FOR THE PREPARATION OF ISOXAZOLINE-SUBSTITUTED AMIDE COMPOUNDS AND ITS INTERMEDIATES THEREOF
The present invention relates to a process for the preparation of isoxazoline-substituted amide compounds and its intermediates thereof.
The present invention, particularly, relates to a process ...
ABSTRACT
“A 5-(CHLOROMETHYL)-2,4-DIFLUOROPYRIDINE AND PREPARATION THEREOF”
The present invention relates to a process for preparation of 5-(chloromethyl)-2, 4-difluoropyridine of formula (I).
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF 4-ACETYL-2-METHYL-BENZONITRILE
The present invention relates to an improved process for the preparation of 4-acetyl-2-methyl-benzonitrile of formula (I). The present invention further provides an improved process for the preparation of isoxazoline derivatives...
ABSTRACT
A NOVEL POLYMORPH OF SITAGLIPTIN HYDROCHLORIDE AND PROCESS FOR ITS PREPARATION THEREOF
The present invention provides a novel polymorphic form of Sitagliptin hydrochloride and processes for its preparation thereof.
ABSTRACT
“AN IMPROVED PROCESS FOR THE PREPARATION OF
ETHYL (Z)-2-CHLORO-2-(2-(4-METHOXYPHENYL) HYDRAZINYLIDENE) ACETATE”
The present invention relates to an improved process for the preparation of ethyl (z)-2-chloro-2-(2-(4-methoxyphenyl) hydrazinylidene) acetate formula (I).
ABSTRACT
“A PROCESS FOR THE PREPARATION OF1-(4-NITROPHENYL) PIPERIDIN-2-ONE”
The present invention relates to a process for the preparation of 1-(4-Nitrophenyl) piperidin-2-one of formula (I). The present invention further relates to a process for the preparation of 1-(4-Nitrophenyl) piperidin-2-one by oxidati...
ABSTRACT
A PROCESS FOR THE PREPARATION OF EDOXABAN AND ITS INTERMEDIATE
The present invention relates to a process for preparation of Edoxaban intermediate namely alkyl 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate compound of Formula-I.
The present invention also relates to a process for the preparation of ...
Registered Trademarks
[Class : 1] Chemical Preparations For Use In The Manufacture Of Biocides
[Class : 5] Biocides, Natural Biocides, Synthetic Biocides Included In Class 5
[Class : 2] Preservatives, Preservatives Used In Paint Industry, And Other Preservatives Included In Class 02
View +15 more Brands for Hikal Limited.
Charges
05 September 2018
Hdfc Bank Limited
75 Crore
03 June 2016
Axis Trustee Services Limited
106 Crore
20 November 2015
Axis Trustee Services Limited
260 Crore
20 January 2012
Icici Bank Ltd.
10 Crore
30 July 2011
State Bank Of Hyderabad
15 Crore
17 December 2007
Dbs Bank Ltd.
20 Crore
31 January 2007
Axis Bank Limited
385 Crore
18 March 2005
Uti Bank Ltd
30 Crore
01 March 2005
Uti Bank Ltd
30 Crore
24 November 2004
Cooperative Centralle Raiffeisen Boernileen Bank B.a.
54 Lak
26 August 2004
Export-import Bank Of India
14 Crore
29 August 2000
Export Import Bank Of India
23 Lak
25 July 2000
Uti Bank Ltd.
30 Crore
03 June 1999
Bank Of Baroda
2 Crore
29 August 1997
Icici Limited
15 Crore
25 November 1994
Bank Of Baroda
1 Crore
09 April 1988
Canara Bank
9 Lak
09 April 1988
Canara Bank
3 Lak
23 September 2014
International Finance Corporation
48 Crore
24 April 2009
International Finance Corporation
75 Crore
27 February 2012
Yes Bank Limited
15 Crore
25 September 2009
Standard Chartered Bank
20 Crore
30 October 2013
Icici Bank Limited
20 Crore
25 March 2010
Idbi Bank Ltd.
40 Crore
07 October 2010
Standard Chartered Bank
50 Crore
26 August 2014
Rbl Bank Limited
15 Crore
14 September 2010
Export Import Bank Of India
65 Crore
13 October 2010
Idbi Bank Limited
40 Crore
03 April 2012
Icici Bank Limited
30 Crore
25 September 2012
Aditya Birla Finance Limited
15 Crore
28 February 2012
Export Import Bank Of India
30 Crore
31 July 2014
Standard Chartered Bank
75 Crore
27 February 2015
Standard Chartered Bank
75 Crore
25 October 2013
Kotak Mahindra Bank Limited
25 Crore
19 March 2008
Export-import Bank Of India
55 Crore
16 June 2000
Export Import Bank Of India
7 Crore
21 October 2003
Export- Import Bank Of India
17 Lak
28 March 2002
Export Import Bank Of India
22 Crore
17 July 2009
Export Import Bank Of India
25 Crore
03 March 2009
State Bank Of India
40 Crore
15 May 2007
Icici Bank Limited
41 Crore
17 December 2007
Dbs Bank Ltd.
17 Crore
17 December 2007
Bank Of Baroda
10 Crore
17 December 2007
Abn-amro Bank N.v.
20 Crore
17 December 2007
Citibank N.a.
35 Crore
17 December 2007
Hdfc Bank Limited
17 Crore
11 May 2007
State Bank Of India
25 Crore
02 April 2009
State Bank Of India
20 Crore
25 July 2000
Uti Bank Limited
30 Crore
17 December 2007
Union Bank Of India
16 Crore
12 February 1996
Union Bank Of India
1 Crore
12 February 1996
Union Bank Of India
9 Crore
17 November 1997
Union Bank Of India
52 Crore
26 April 1996
Bank Of Baroda
12 Crore
17 November 1997
Bank Of Baroda(leadbank)
52 Crore
16 July 1990
Bank Of Baroda
3 Crore
04 October 1993
Bank Of Baroda
6 Crore
25 January 2006
Idbi Limited
15 Crore
30 April 2002
Rado India Finance Pvt. Ltd.
15 Crore
16 June 2000
Eexport Import Bank Of India
0
26 September 2003
Uti Bank Ltd.
0
25 July 2000
Uti Bank Limited
0
13 July 1999
Export Import Bank Of India
11 Crore
23 January 1996
Export Import Bank Of India
31 Crore
29 January 1998
The Sumitomo Bank Ltd.
8 Crore
14 November 1994
Housing Development Finance Corporation Ltd.
46 Lak
01 August 1994
Housing Development Finance Corporation Ltd.
40 Lak
21 July 2020
Export-import Bank Of India
250 Crore
13 December 2019
Kotak Mahindra Bank Limited
75 Crore
26 August 2019
Kotak Mahindra Bank Limited
75 Crore
01 August 2023
Others
0
08 November 2022
Others
0
21 July 2020
Others
0
26 August 2019
Others
0
13 December 2019
Others
0
03 June 1999
Bank Of Baroda
0
31 January 2007
Axis Bank Limited
0
03 June 2016
Others
0
24 April 2009
Others
0
27 February 2012
Yes Bank Limited
0
30 October 2013
Icici Bank Limited
0
11 May 2007
State Bank Of India
0
19 March 2008
Export-import Bank Of India
0
17 December 2007
Hdfc Bank Limited
0
17 December 2007
Abn-amro Bank N.v.
0
02 April 2009
State Bank Of India
0
17 December 2007
Bank Of Baroda
0
17 July 2009
Export Import Bank Of India
0
25 March 2010
Idbi Bank Ltd.
0
07 October 2010
Standard Chartered Bank
0
30 July 2011
State Bank Of Hyderabad
0
20 January 2012
Icici Bank Ltd.
0
28 February 2012
Export Import Bank Of India
0
25 September 2012
Aditya Birla Finance Limited
0
25 October 2013
Kotak Mahindra Bank Limited
0
25 July 2000
Uti Bank Limited
0
26 August 2004
Export-import Bank Of India
0
25 January 2006
Idbi Limited
0
12 February 1996
Union Bank Of India
0
09 April 1988
Canara Bank
0
14 November 1994
Housing Development Finance Corporation Ltd.
0
16 July 1990
Bank Of Baroda
0
04 October 1993
Bank Of Baroda
0
23 January 1996
Export Import Bank Of India
0
29 August 1997
Icici Limited
0
17 November 1997
Union Bank Of India
0
16 June 2000
Export Import Bank Of India
0
28 March 2002
Export Import Bank Of India
0
30 April 2002
Rado India Finance Pvt. Ltd.
0
26 September 2003
Uti Bank Ltd.
0
21 October 2003
Export- Import Bank Of India
0
17 November 1997
Bank Of Baroda(leadbank)
0
01 March 2005
Uti Bank Ltd
0
18 March 2005
Uti Bank Ltd
0
05 September 2018
Hdfc Bank Limited
0
24 November 2004
Cooperative Centralle Raiffeisen Boernileen Bank B.a.
0
17 December 2007
Dbs Bank Ltd.
0
17 December 2007
Citibank N.a.
0
03 March 2009
State Bank Of India
0
17 December 2007
Union Bank Of India
0
17 December 2007
Dbs Bank Ltd.
0
25 September 2009
Standard Chartered Bank
0
14 September 2010
Export Import Bank Of India
0
13 October 2010
Idbi Bank Limited
0
03 April 2012
Icici Bank Limited
0
31 July 2014
Standard Chartered Bank
0
26 August 2014
Rbl Bank Limited
0
23 September 2014
Others
0
27 February 2015
Standard Chartered Bank
0
20 November 2015
Others
0
25 July 2000
Uti Bank Limited
0
16 June 2000
Eexport Import Bank Of India
0
12 February 1996
Union Bank Of India
0
09 April 1988
Canara Bank
0
01 August 1994
Housing Development Finance Corporation Ltd.
0
25 November 1994
Bank Of Baroda
0
26 April 1996
Bank Of Baroda
0
29 January 1998
The Sumitomo Bank Ltd.
0
13 July 1999
Export Import Bank Of India
0
25 July 2000
Uti Bank Ltd.
0
29 August 2000
Export Import Bank Of India
0
15 May 2007
Icici Bank Limited
0
01 August 2023
Others
0
08 November 2022
Others
0
21 July 2020
Others
0
26 August 2019
Others
0
13 December 2019
Others
0
03 June 1999
Bank Of Baroda
0
31 January 2007
Axis Bank Limited
0
03 June 2016
Others
0
24 April 2009
Others
0
27 February 2012
Yes Bank Limited
0
30 October 2013
Icici Bank Limited
0
11 May 2007
State Bank Of India
0
19 March 2008
Export-import Bank Of India
0
17 December 2007
Hdfc Bank Limited
0
17 December 2007
Abn-amro Bank N.v.
0
02 April 2009
State Bank Of India
0
17 December 2007
Bank Of Baroda
0
17 July 2009
Export Import Bank Of India
0
25 March 2010
Idbi Bank Ltd.
0
07 October 2010
Standard Chartered Bank
0
30 July 2011
State Bank Of Hyderabad
0
20 January 2012
Icici Bank Ltd.
0
28 February 2012
Export Import Bank Of India
0
25 September 2012
Aditya Birla Finance Limited
0
25 October 2013
Kotak Mahindra Bank Limited
0
25 July 2000
Uti Bank Limited
0
26 August 2004
Export-import Bank Of India
0
25 January 2006
Idbi Limited
0
12 February 1996
Union Bank Of India
0
09 April 1988
Canara Bank
0
14 November 1994
Housing Development Finance Corporation Ltd.
0
16 July 1990
Bank Of Baroda
0
04 October 1993
Bank Of Baroda
0
23 January 1996
Export Import Bank Of India
0
29 August 1997
Icici Limited
0
17 November 1997
Union Bank Of India
0
16 June 2000
Export Import Bank Of India
0
28 March 2002
Export Import Bank Of India
0
30 April 2002
Rado India Finance Pvt. Ltd.
0
26 September 2003
Uti Bank Ltd.
0
21 October 2003
Export- Import Bank Of India
0
17 November 1997
Bank Of Baroda(leadbank)
0
01 March 2005
Uti Bank Ltd
0
18 March 2005
Uti Bank Ltd
0
05 September 2018
Hdfc Bank Limited
0
24 November 2004
Cooperative Centralle Raiffeisen Boernileen Bank B.a.
0
17 December 2007
Dbs Bank Ltd.
0
17 December 2007
Citibank N.a.
0
03 March 2009
State Bank Of India
0
17 December 2007
Union Bank Of India
0
17 December 2007
Dbs Bank Ltd.
0
25 September 2009
Standard Chartered Bank
0
14 September 2010
Export Import Bank Of India
0
13 October 2010
Idbi Bank Limited
0
03 April 2012
Icici Bank Limited
0
31 July 2014
Standard Chartered Bank
0
26 August 2014
Rbl Bank Limited
0
23 September 2014
Others
0
27 February 2015
Standard Chartered Bank
0
20 November 2015
Others
0
25 July 2000
Uti Bank Limited
0
16 June 2000
Eexport Import Bank Of India
0
12 February 1996
Union Bank Of India
0
09 April 1988
Canara Bank
0
01 August 1994
Housing Development Finance Corporation Ltd.
0
25 November 1994
Bank Of Baroda
0
26 April 1996
Bank Of Baroda
0
29 January 1998
The Sumitomo Bank Ltd.
0
13 July 1999
Export Import Bank Of India
0
25 July 2000
Uti Bank Ltd.
0
29 August 2000
Export Import Bank Of India
0
15 May 2007
Icici Bank Limited
0
Documents
Form BEN - 2-31122020_signed
Form BEN - 2-30122020_signed
Form BEN - 2-29122020_signed
Form BEN - 2-28122020_signed
Declaration under section 90-28122020
Form DIR-12-04122020_signed
Evidence of cessation;-03122020
Notice of resignation;-03122020
Optional Attachment-(1)-03122020
Optional Attachment-(1)-13112020
Copy of MGT-8-13112020
HIKAL-Shareholders-MGT_7-3103_R71050009_SHAMHIKAL_20201113135536.xls
Form MGT-7-13112020_signed
Form MSME FORM I-30102020_signed
Form DPT-3-19102020-signed
Form MGT-14-13102020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-13102020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-13102020
XBRL document in respect Consolidated financial statement-13102020
Optional Attachment-(1)-13102020
Form AOC-4(XBRL)-13102020_signed
Form MGT-15-02102020_signed
Optional Attachment-(2)-17082020
Optional Attachment-(1)-17082020
Notice of resignation;-17082020
Form DIR-12-17082020_signed
Evidence of cessation;-17082020
Form MGT-14-13082020_signed
Optional Attachment-(1)-13082020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-13082020
